G. Ganem

7.0k total citations · 1 hit paper
68 papers, 4.5k citations indexed

About

G. Ganem is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, G. Ganem has authored 68 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 16 papers in Pathology and Forensic Medicine and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in G. Ganem's work include Cancer Treatment and Pharmacology (12 papers), Colorectal Cancer Treatments and Studies (9 papers) and Lymphoma Diagnosis and Treatment (9 papers). G. Ganem is often cited by papers focused on Cancer Treatment and Pharmacology (12 papers), Colorectal Cancer Treatments and Studies (9 papers) and Lymphoma Diagnosis and Treatment (9 papers). G. Ganem collaborates with scholars based in France, Belgium and United States. G. Ganem's co-authors include Christophe Tournigand, Gérard Lledo, Emmanuel Achille, Thierry André, Marc Buyse, Aimery de Gramont, C. Couteau, Philippe Colin, D. Méry-Mignard and Bruno Landi and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

G. Ganem

66 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study

2003 2.3k citations Christophe Tournigand, Thierry André et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by G. Ganem

Since Specialization

Citations

This map shows the geographic impact of G. Ganem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Ganem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Ganem more than expected).

Fields of papers citing papers by G. Ganem

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Ganem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Ganem. The network helps show where G. Ganem may publish in the future.

Co-authorship network of co-authors of G. Ganem

This figure shows the co-authorship network connecting the top 25 collaborators of G. Ganem. A scholar is included among the top collaborators of G. Ganem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Ganem. G. Ganem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Infection à SARS-CoV-2/COVID 19 et cancers solides : synthèse des recommandations à l’attention des professionnels de santé 2020 ·Bulletin du Cancer ·Thomas Grellety, Alain Ravaud, (unknown), G. Ganem, P. Giraud, Rosine Guimbaud, Laure Kaluzinski, I. Krakowski, Didier Mayeur, Jean‐Pierre Lotz, Benoît You	16
2	Prise en charge des patients sous voies orales anticancéreuses au domicile en Bretagne et Pays de la Loire : enquête fin 2016 et cartographie 2019 ·Bulletin du Cancer ·(unknown), (unknown), (unknown), (unknown), Marc Pracht, Hugues Bourgeois, (unknown), Jean‐Philippe Metges, (unknown), G. Ganem	4
3	Cancer de l’œsophage 2010 ·Cancer/Radiothérapie ·Olivier Dupuis, G. Ganem, G. Béra, Y. Pointreau, Olivier Pradier, P. Martin, X. Mirabel, Fabrice Denis	5
4	Localized Low-Dose Radiotherapy for Follicular Lymphoma: History, Clinical Results, Mechanisms of Action, and Future Outlooks 2010 ·International Journal of Radiation OncologyBiologyPhysics ·G. Ganem, Guillaume Cartron, T. Girinsky, Rick L. Haas, J.M. Cosset, Philippe Solal‐Céligny	31
5	À propos de la mise en place des soins de support en cancérologie: pistes de réflexions et propositions 2009 ·Bulletin du Cancer ·Philippe Colombat, S. Antoun, Régis Aubry, (unknown), F. Barruel, (unknown), (unknown), (unknown), (unknown), Gisèle Chvetzoff, (unknown), (unknown), (unknown), G. Ganem, I. Krakowski, (unknown), (unknown), (unknown), Agnès Suc	3
6	CHOP Alone Compared With CHOP Plus Radiotherapy for Localized Aggressive Lymphoma in Elderly Patients: A Study by the Groupe d’Etude des Lymphomes de l’Adulte 2007 ·Journal of Clinical Oncology ·Christophe Bonnet, Georges Fillet, Nicolas Mounier, G. Ganem, Thierry Jo Molina, Catherine Thiéblemont, Christophe Fermé, Bruno Quesnel, C. Martin, Christian Gisselbrecht, Hervé Tilly, Félix Reyes	161
7	Traitement adjuvant du cancer du côlon : principaux résultats de l’étude MOSAIC* 2006 ·Bulletin du Cancer ·Thierry André, Christophe Tournigand, Emmanuel Achille, N. Tubiana-Mathieu, Gérard Lledo, (unknown), Élisabeth Carola, M. Flesch, Thierry Muron, Arnaud Boutan-Laroze, (unknown), C Boaziz, Michel Maigre, G. Ganem, Mireille Mousseau, (unknown), Aimery de Gramont	1
8	Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study 2005 ·Annals of Oncology ·Gilles Freyer, J.-F. Geay, Sandrine Touzet, J. Provençal, B. Weber, J.P. Jacquin, G. Ganem, N. Tubiana-Mathieu, O. Gisserot, Éric Pujade-Lauraine	251
9	FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study breakdown → 2003 ·Journal of Clinical Oncology ·Christophe Tournigand, Thierry André, Emmanuel Achille, Gérard Lledo, (unknown), D. Méry-Mignard, Emmanuel Quinaux, C. Couteau, Marc Buyse, G. Ganem, Bruno Landi, Philippe Colin, Christophe Louvet, Aimery de Gramont	2290
10	Phase II trial combining docetaxel and doxorubicin as neoadjuvant chemotherapy in patients with operable breast cancer 2003 ·Annals of Oncology ·G. Ganem, M. Tubiana-Hulin, P. Fumoleau, M. Combe, J. L. Misset, Jean-Michel Vannetzel, Thomas Bachelot, (unknown), (unknown), Belguendouz Bendahmane, Véronique Dièras	35
11	[Standards, Options and Recommendations for the management of patient with carcinoma of unknown primary site]. 2002 ·PubMed ·R. Bugat, A Bataillard, Thierry Lesimple, Jean‐Jacques Voigt, Stéphane Culine, Alain Lortholary, Yacine Merrouche, G. Ganem, Marie‐Christine Kaminsky, Sylvie Négrier, M. Pérol, (unknown), Pierre Bédossa, G. Bertrand, Jean‐Michel Coindre, Karim Fizazi, (unknown)	17
12	A high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: analysis of predictive parameters of response to treatment 2001 ·International Journal of Radiation OncologyBiologyPhysics ·T. Girinsky, (unknown), Serge Koscielny, (unknown), G. Ganem, Patrice Carde, (unknown), Renata Junqueira Pereira, Jacques Bosq, Vincent Ribrag, J Vantelon, Jean‐Nicolas Munck	52
13	Radiation myositis: The possible role of gemcitabine 2000 ·Annals of Oncology ·G. Ganem, P. Solal-Céligny, A Joffroy, (unknown), (unknown), Olivier Dupuis	24
14	Potential role for low dose limited‐field radiation therapy (2 × 2 grays) in advanced low‐grade non‐Hodgkin's lymphomas 1994 ·Hematological Oncology ·G. Ganem, Philippe Lambin, Gèrard Socié, T. Girinsky, Jacques Bosq, José Luis Pico, Philippe Solal‐Céligny, J.M. Cosset	63
15	Interstitial pneumonitis and venocclusive disease of the liver after bone marrow transplantation 1990 ·Radiotherapy and Oncology ·Pascal Piedbois, G. Ganem, Catherine Cordonnier, Carlos Emílio Levy, V. Benk, (unknown), (unknown), Mathieu Kuentz, G. Marinello, J.J. Mazeron, Daniel Dhumeaux, (unknown), J.P. Le Bourgeois	7
16	Central nervous system relapses after bone marrow transplantation for acute lymphoblastic leukemia in remission 1989 ·Cancer ·G. Ganem, Mathieu Kuentz, Françoise Bernaudin, (unknown), Catherine Cordonnier, S. Lemerle, (unknown), G Vinci, H Rochant, (unknown), Jean Paul Vernant	27
17	Venocclusive disease of the liver after allogeneic bone marrow transplantation in man 1988 ·International Journal of Radiation OncologyBiologyPhysics ·G. Ganem, (unknown), Mathieu Kuentz, Catherine Cordonnier, G. Marinello, (unknown), F Braconnier, Jean‐Paul Vernant, Daniel Dhumeaux, Jean‐Paul Le Bourgeois	53
18	Treatment of inflammatory breast cancer with combination chemotherapy and mastectomy versus breast conservation 1988 ·Cancer ·Bernard Brun, Y. Otmezguine, F Feuilhade, M Julien, (unknown), É. Calitchi, (unknown), G. Ganem, Judith Huart, B Pierquin	51
19	Establishment and characterization of three transplantable EBV‐containing nasopharyngeal carcinomas 1988 ·International Journal of Cancer ·Pierre Busson, G. Ganem, (unknown), Francine Mugneret, Bernard Clausse, Bernard Caillou, K Braham, Hiro Wakasugi, Marta M. Lipinski, Thomas Tursz	189
20	Definitive radiation treatment for early stage carcinoma of the soft palate and uvula: The indications for iridium 192 implantation 1987 ·International Journal of Radiation OncologyBiologyPhysics ·Jean‐Jacques Mazeron, G. Marinello, Juanita Crook, Lorraine Marin, (unknown), Michel Raynal, É. Calitchi, R Peynègre, G. Ganem, (unknown), Judith Huart, Jean‐Paul Le Bourgeois, B Pierquin	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact